Esterline Technologies (ESL) Tops Q4 EPS by 34c; Guides FY16 In-Line

Esterline Technologies (NYSE: ESL) reported Q4 EPS of $1.33, $0.34 better than the analyst estimate of $0.99. Revenue for the quarter came in at $349.6 million versus the consensus estimate of $343.14 million.

Esterline Technologies sees FY2016 EPS of $5.50-$5.80, versus the consensus of $5.80. Esterline Technologies sees FY2016 revenue of $2.03-2.08 billion, versus the consensus of $2.05 billion.

Curtis Reusser, Esterline's Chief Executive Officer, said, "2015 marked an important year for Esterline, as we navigated through strategic initiatives that touched many aspects of our business. Operationally this included continued progress on our accelerated integration, strategic sourcing and continuous improvement activities as well as reshaping our business portfolio. Also, we refinanced our outstanding debt, adjusted our reporting calendar to better align with our industry, and returned $260 million of cash to shareholders through our share repurchase program."

Reusser continued, "While 2015 was a challenging year by many measures, I'm pleased with the focus of our teams to successfully execute on our plans and finish on a strong note."

For earnings history and earnings-related data on Esterline Technologies (ESL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c